Geode Capital Management’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-107,897
Closed -$24.3K 4724
2023
Q4
$24.3K Hold
107,897
﹤0.01% 4481
2023
Q3
$34.8K Hold
107,897
﹤0.01% 4516
2023
Q2
$100K Hold
107,897
﹤0.01% 4333
2023
Q1
$94.4K Hold
107,897
﹤0.01% 4357
2022
Q4
$183K Sell
107,897
-285
-0.3% -$629 ﹤0.01% 4150
2022
Q3
$225K Hold
108,182
﹤0.01% 4141
2022
Q2
$279K Hold
108,182
﹤0.01% 4068
2022
Q1
$472K Sell
108,182
-21
-0% -$88 ﹤0.01% 3961
2021
Q4
$493K Sell
108,203
-12
-0% -$65 ﹤0.01% 4053
2021
Q3
$650K Buy
108,215
+23,593
+28% +$170K ﹤0.01% 3904
2021
Q2
$875K Sell
84,622
-49,866
-37% -$476K ﹤0.01% 3674
2021
Q1
$1.03M Buy
134,488
+70,507
+110% +$467K ﹤0.01% 3552
2020
Q4
$241K Buy
63,981
+4,408
+7% +$17K ﹤0.01% 3830
2020
Q3
$211K Buy
59,573
+16,628
+39% +$97.1K ﹤0.01% 3705
2020
Q2
$397K Buy
+42,945
New +$306K ﹤0.01% 3448

Other funds holding NMRD

Geode Capital Management's NMRD Position: Q1 2024 in Review

Geode Capital Management sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 107,897 shares — an estimated $24.3K sold.

Geode Capital Management first reported a position in NMRD in Q2 2020 and held it in 15 quarters. The position peaked at $1.03M in Q1 2021. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Geode Capital Management reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 107,897 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $24.3K.
  • Geode Capital Management first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Geode Capital Management's Nemaura Medical, Inc. Common Stock position peaked at $1.03M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.